APO-APIXABAN 2.5 MG
APIXABAN : 2.5 MG · DIN 02487381 · APOTEX INC
Health Canada status: MARKETED
What is APO-APIXABAN?
APO-APIXABAN 2.5 MG contains APIXABAN : 2.5 MG. It is listed in the Health Canada Drug Product Database under DIN 02487381, held by APOTEX INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 20-Jun-2022. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is APO-APIXABAN used for?
APO-APIXABAN (apixaban) is indicated for the prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective knee or hip replacement surgery, the prevention of stroke and systemic embolism in patients with atrial fibrillation, and the treatment of venous thromboembolic events (deep vein thrombosis [DVT], pulmonary embolism [PE]) and prevention of recurrent DVT and PE.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02487381 |
|---|---|
| Brand name | APO-APIXABAN |
| Generic / active ingredient | APIXABAN : 2.5 MG |
| Manufacturer | APOTEX INC |
| Strength | 2.5 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | B01AF02 APIXABAN |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 20-Jun-2022 |
How is it stored and handled?
null
How is it supplied?
null
Is APIXABAN in shortage in Canada?
A Canadian shortage report is on file for this molecule: Active — reported by SANIS HEALTH INC (Tier 3 Drug Shortages About & Resources), last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code B01AF02 APIXABAN. 43 of 44 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACH-APIXABAN | 2.5 MG | TABLET | ACCORD HEALTHCARE INC | MARKETED | DIN 02487713 |
| ACH-APIXABAN | 5 MG | TABLET | ACCORD HEALTHCARE INC | MARKETED | DIN 02487721 |
| AG-APIXABAN | 2.5 MG | TABLET | ANGITA PHARMA INC. | MARKETED | DIN 02529912 |
| AG-APIXABAN | 5 MG | TABLET | ANGITA PHARMA INC. | MARKETED | DIN 02529920 |
| APIXABAN | 2.5 MG | TABLET | SANIS HEALTH INC | MARKETED | DIN 02548879 |
| APIXABAN | 2.5 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02530708 |
| APIXABAN | 5 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02530716 |
| APIXABAN | 5 MG | TABLET | SANIS HEALTH INC | MARKETED | DIN 02548887 |
| APO-APIXABAN | 5 MG | TABLET | APOTEX INC | MARKETED | DIN 02487403 |
| AURO-APIXABAN | 2.5 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02486806 |
Who else supplies APIXABAN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. APIXABAN appears in 573 registered pack listings across 13 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.